Location History:
- Boston, MA (US) (1998 - 2001)
- Norwood, MA (US) (2001)
Company Filing History:
Years Active: 1998-2001
Title: The Innovations of Meiheng Yang
Introduction
Meiheng Yang is a notable inventor based in Norwood, MA (US). He has made significant contributions to the field of biotechnology, particularly in cancer research. With a total of 3 patents, his work focuses on the modulation of tumor cell responses.
Latest Patents
One of Yang's latest patents involves the NPG-1 gene, which is differentially expressed in prostate tumors. This invention provides isolated nucleic acid molecules, designated as NPG-1 nucleic acid molecules, which encode polypeptides involved in modulating responses in tumor cells. The invention also includes antisense nucleic acid molecules, expression vectors containing NPG-1 nucleic acid molecules, and host cells that have been introduced to these expression vectors. Furthermore, it encompasses non-human transgenic animals in which the NPG-1 gene has been introduced or disrupted. The invention also provides isolated NPG-1 polypeptides, fusion polypeptides, antigenic peptides, and anti-NPG-1 antibodies. Diagnostic, screening, and therapeutic methods utilizing the compositions of this invention are also included.
Career Highlights
Meiheng Yang is affiliated with Beth Israel Deaconess Medical Center, Inc., where he continues to advance his research and innovations. His work has been instrumental in understanding the genetic factors involved in prostate cancer.
Collaborations
Yang collaborates with various professionals in his field, including his coworker Arthur J Sytkowski, to further enhance the impact of his research.
Conclusion
Meiheng Yang's contributions to biotechnology and cancer research through his innovative patents highlight the importance of genetic research in developing diagnostic and therapeutic methods. His work continues to pave the way for advancements in understanding and treating prostate tumors.